43742-1371 NDC - FEMALE STIMULANT (LILIUM TIGRINUM, BOVISTA, CYPRIPEDIUM PUBESCENS, HYDRASTIS CANADENSIS, APIOLUM, APIS VENENUM PURUM, AQUILEGIA VULGARIS, FUNICULUS UMBILICALIS SUIS, GLANDULA SUPRARENALIS SUIS, HEART (SUIS), KREOSOTUM, OOPHORINUM (SUIS), UTERUS (SUIS), FOLLICULINUM, ACONITICUM ACIDUM, CIS-, LACHESIS MUTUS, MAGNESIA PHOSPHORICA, MERCURIUS SOLUBILIS, SEPIA, PINEAL GLAND (SUIS), HYPOPHYSIS SUIS, ESTRADIOL, PROGESTERONE, TESTOSTERONE, PLACENTA TOTALIS SUIS, BACILLUS FAECALIS, MUTABILE BACILLUS (BACH))

Drug Information

Product NDC: 43742-1371

Proprietary Name: Female Stimulant

Non Proprietary Name: Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Apiolum, Apis Venenum Purum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (Suis), Kreosotum, Oophorinum (Suis), Uterus (Suis), Folliculinum, Aconiticum Acidum, CIS-, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (Suis), Hypophysis Suis, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Bacillus Faecalis, Mutabile Bacillus (Bach)

Active Ingredient(s):
  • 10 [hp_X]/mL ACONITIC ACID, (Z)-;
  • 30 [hp_C]/mL ALCALIGENES FAECALIS;
  • 6 [hp_X]/mL APIOLE (PARSLEY);
  • 8 [hp_X]/mL APIS MELLIFERA VENOM;
  • 8 [hp_X]/mL AQUILEGIA VULGARIS;
  • 6 [hp_X]/mL CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT;
  • 30 [hp_C]/mL ESCHERICHIA COLI;
  • 30 [hp_X]/mL ESTRADIOL;
  • 8 [hp_X]/mL ESTRONE;
  • 6 [hp_X]/mL GOLDENSEAL;
  • 10 [hp_X]/mL LACHESIS MUTA VENOM;
  • 4 [hp_X]/mL LILIUM LANCIFOLIUM WHOLE FLOWERING;
  • 6 [hp_X]/mL LYCOPERDON UTRIFORME FRUITING BODY;
  • 10 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE;
  • 10 [hp_X]/mL MERCURIUS SOLUBILIS;
  • 8 [hp_X]/mL PORK HEART;
  • 30 [hp_X]/mL PROGESTERONE;
  • 10 [hp_X]/mL SEPIA OFFICINALIS JUICE;
  • 8 [hp_X]/mL SUS SCROFA ADRENAL GLAND;
  • 8 [hp_X]/mL SUS SCROFA OVARY;
  • 12 [hp_X]/mL SUS SCROFA PINEAL GLAND;
  • 13 [hp_X]/mL SUS SCROFA PITUITARY GLAND;
  • 6 [hp_C]/mL SUS SCROFA PLACENTA;
  • 8 [hp_X]/mL SUS SCROFA UMBILICAL CORD;
  • 8 [hp_X]/mL SUS SCROFA UTERUS;
  • 30 [hp_X]/mL TESTOSTERONE;
  • 8 [hp_X]/mL WOOD CREOSOTE


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Androgen Receptor Agonists [MoA];
  • Androgen [EPC];
  • Androstanes [CS];
  • Calculi Dissolution Agent [EPC];
  • Estradiol Congeners [CS];
  • Estrogen Receptor Agonists [MoA];
  • Estrogen [EPC];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE];
  • Magnesium Ion Exchange Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Progesterone [CS];
  • Progesterone [EPC];
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:5/17/2019
End Marketing Date:10/23/2025
DEA Schedule:CIII

Package Information

No. Package Code Package Description Billing Unit
143742-1371-130 mL in 1 BOTTLE, DROPPER (43742-1371-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-1371The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEFemale StimulantThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMELilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Apiolum, Apis Venenum Purum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (Suis), Kreosotum, Oophorinum (Suis), Uterus (Suis), Folliculinum, Aconiticum Acidum, CIS-, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (Suis), Hypophysis Suis, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Bacillus Faecalis, Mutabile Bacillus (Bach)The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/17/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE10/23/2025This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACONITIC ACID, (Z)-; ALCALIGENES FAECALIS; APIOLE (PARSLEY); APIS MELLIFERA VENOM; AQUILEGIA VULGARIS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; ESCHERICHIA COLI; ESTRADIOL; ESTRONE; GOLDENSEAL; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; PORK HEART; PROGESTERONE; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA UTERUS; TESTOSTERONE; WOOD CREOSOTEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH10; 30; 6; 8; 8; 6; 30; 30; 8; 6; 10; 4; 6; 10; 10; 8; 30; 10; 8; 8; 12; 13; 6; 8; 8; 30; 8 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAndrogen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Calculi Dissolution Agent [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Progesterone [CS], Progesterone [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 
DEA SCHEDULECIIIThis is the assigned DEA Schedule number as reported by the labeler. Values are CI, CII, CIII, CIV, and CV.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023